Review on the clinical pharmacology of hydroxychloroquine sulfate for the treatment of COVID-19.
CONCLUSION: It has been proved that HCQ, which has an established safety profile, is effective against SARS-CoV-2 with sufficient pre-clinical rationale and evidence. Data from high-quality clinical trials are urgently needed worldwide.
PMID: 32520683 [PubMed - as supplied by publisher]
Source: Current Drug Metabolism - Category: Drugs & Pharmacology Authors: Cui C, Tu S, En VSJ, Li X, Yao X, Li H, Liu D Tags: Curr Drug Metab Source Type: research
More News: Clinical Trials | Coronavirus | COVID-19 | Drugs & Pharmacology | Hydroxychloroquine | Respiratory Medicine | SARS | Stem Cell Therapy | Stem Cells | Study | USA Health | Vaccines